Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

Cited In for PubMed (Select 14968935)

1.

GPS2 is required for the association of NS5A with VAP-A and hepatitis C virus replication.

Xu G, Xin X, Zheng C.

PLoS One. 2013 Nov 4;8(11):e78195. doi: 10.1371/journal.pone.0078195. eCollection 2013.

2.

VAPC, an human endogenous inhibitor for hepatitis C virus (HCV) infection, is intrinsically unstructured but forms a "fuzzy complex" with HCV NS5B.

Goyal S, Gupta G, Qin H, Upadya MH, Tan YJ, Chow VT, Song J.

PLoS One. 2012;7(7):e40341. doi: 10.1371/journal.pone.0040341. Epub 2012 Jul 17.

3.

Intrinsically unstructured domain 3 of hepatitis C Virus NS5A forms a "fuzzy complex" with VAPB-MSP domain which carries ALS-causing mutations.

Gupta G, Qin H, Song J.

PLoS One. 2012;7(6):e39261. doi: 10.1371/journal.pone.0039261. Epub 2012 Jun 13.

4.

CD44 participates in IP-10 induction in cells in which hepatitis C virus RNA is replicating, through an interaction with Toll-like receptor 2 and hyaluronan.

Abe T, Fukuhara T, Wen X, Ninomiya A, Moriishi K, Maehara Y, Takeuchi O, Kawai T, Akira S, Matsuura Y.

J Virol. 2012 Jun;86(11):6159-70. doi: 10.1128/JVI.06872-11. Epub 2012 Apr 4.

5.

Establishment of a novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR122.

Kambara H, Fukuhara T, Shiokawa M, Ono C, Ohara Y, Kamitani W, Matsuura Y.

J Virol. 2012 Feb;86(3):1382-93. doi: 10.1128/JVI.06242-11. Epub 2011 Nov 23.

6.

Interactions between Hsp90 and oncogenic viruses: implications for viral cancer therapeutics.

Defee MR, Qin Z, Dai L, Isaacs JS, Parsons CH.

Am J Cancer Res. 2011;1(6):763-72. Epub 2011 Jun 5.

7.

Dysfunction of autophagy participates in vacuole formation and cell death in cells replicating hepatitis C virus.

Taguwa S, Kambara H, Fujita N, Noda T, Yoshimori T, Koike K, Moriishi K, Matsuura Y.

J Virol. 2011 Dec;85(24):13185-94. doi: 10.1128/JVI.06099-11. Epub 2011 Oct 12.

8.

Elimination of hepatitis C virus from hepatocytes by a selective activation of therapeutic molecules.

Wen X, Abe T, Kukihara H, Taguwa S, Mori Y, Tani H, Kato N, Suzuki T, Tatsumi M, Moriishi K, Matsuura Y.

PLoS One. 2011 Jan 6;6(1):e15967. doi: 10.1371/journal.pone.0015967.

9.

Human VAP-C negatively regulates hepatitis C virus propagation.

Kukihara H, Moriishi K, Taguwa S, Tani H, Abe T, Mori Y, Suzuki T, Fukuhara T, Taketomi A, Maehara Y, Matsuura Y.

J Virol. 2009 Aug;83(16):7959-69. doi: 10.1128/JVI.00889-09. Epub 2009 Jun 10.

10.

Intramembrane processing by signal peptide peptidase regulates the membrane localization of hepatitis C virus core protein and viral propagation.

Okamoto K, Mori Y, Komoda Y, Okamoto T, Okochi M, Takeda M, Suzuki T, Moriishi K, Matsuura Y.

J Virol. 2008 Sep;82(17):8349-61. doi: 10.1128/JVI.00306-08. Epub 2008 Jun 18.

11.

A single-amino-acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replication.

Okamoto T, Omori H, Kaname Y, Abe T, Nishimura Y, Suzuki T, Miyamura T, Yoshimori T, Moriishi K, Matsuura Y.

J Virol. 2008 Apr;82(7):3480-9. doi: 10.1128/JVI.02253-07. Epub 2008 Jan 23.

12.

Human butyrate-induced transcript 1 interacts with hepatitis C virus NS5A and regulates viral replication.

Taguwa S, Okamoto T, Abe T, Mori Y, Suzuki T, Moriishi K, Matsuura Y.

J Virol. 2008 Mar;82(6):2631-41. Epub 2007 Dec 26.

13.

Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines.

Abe T, Kaname Y, Hamamoto I, Tsuda Y, Wen X, Taguwa S, Moriishi K, Takeuchi O, Kawai T, Kanto T, Hayashi N, Akira S, Matsuura Y.

J Virol. 2007 Sep;81(17):8953-66. Epub 2007 Jun 13.

14.

Replication-competent recombinant vesicular stomatitis virus encoding hepatitis C virus envelope proteins.

Tani H, Komoda Y, Matsuo E, Suzuki K, Hamamoto I, Yamashita T, Moriishi K, Fujiyama K, Kanto T, Hayashi N, Owsianka A, Patel AH, Whitt MA, Matsuura Y.

J Virol. 2007 Aug;81(16):8601-12. Epub 2007 Jun 6.

15.

Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90.

Okamoto T, Nishimura Y, Ichimura T, Suzuki K, Miyamura T, Suzuki T, Moriishi K, Matsuura Y.

EMBO J. 2006 Oct 18;25(20):5015-25. Epub 2006 Oct 5. Erratum in: EMBO J. 2006 Nov 29;25(23):5634.

16.

Oligomerization of hepatitis C virus core protein is crucial for interaction with the cytoplasmic domain of E1 envelope protein.

Nakai K, Okamoto T, Kimura-Someya T, Ishii K, Lim CK, Tani H, Matsuo E, Abe T, Mori Y, Suzuki T, Miyamura T, Nunberg JH, Moriishi K, Matsuura Y.

J Virol. 2006 Nov;80(22):11265-73. Epub 2006 Sep 13.

17.

Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B.

Hamamoto I, Nishimura Y, Okamoto T, Aizaki H, Liu M, Mori Y, Abe T, Suzuki T, Lai MM, Miyamura T, Moriishi K, Matsuura Y.

J Virol. 2005 Nov;79(21):13473-82.

18.

Potential cellular receptors involved in hepatitis C virus entry into cells.

Favre D, Muellhaupt B.

Lipids Health Dis. 2005 Apr 19;4:9. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk